492 related articles for article (PubMed ID: 22252444)
1. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements.
Huang CJ; Lin H; Yang X
J Ind Microbiol Biotechnol; 2012 Mar; 39(3):383-99. PubMed ID: 22252444
[TBL] [Abstract][Full Text] [Related]
2. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
[TBL] [Abstract][Full Text] [Related]
3. Manufacturing of recombinant therapeutic proteins in microbial systems.
Graumann K; Premstaller A
Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
[TBL] [Abstract][Full Text] [Related]
4. Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications.
Gupta SK; Shukla P
Crit Rev Biotechnol; 2016 Dec; 36(6):1089-1098. PubMed ID: 26384140
[TBL] [Abstract][Full Text] [Related]
5. Engineering cell physiology to enhance recombinant protein production in Escherichia coli.
Chou CP
Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257
[TBL] [Abstract][Full Text] [Related]
6. Engineering of therapeutic proteins production in Escherichia coli.
Kamionka M
Curr Pharm Biotechnol; 2011 Feb; 12(2):268-74. PubMed ID: 21050165
[TBL] [Abstract][Full Text] [Related]
7. Advanced genetic strategies for recombinant protein expression in Escherichia coli.
Sørensen HP; Mortensen KK
J Biotechnol; 2005 Jan; 115(2):113-28. PubMed ID: 15607230
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli as a glycoprotein production host: recent developments and challenges.
Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
[TBL] [Abstract][Full Text] [Related]
9. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli.
Fisher AC; Haitjema CH; Guarino C; Çelik E; Endicott CE; Reading CA; Merritt JH; Ptak AC; Zhang S; DeLisa MP
Appl Environ Microbiol; 2011 Feb; 77(3):871-81. PubMed ID: 21131519
[TBL] [Abstract][Full Text] [Related]
10. Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Panda AK
Adv Biochem Eng Biotechnol; 2003; 85():43-93. PubMed ID: 12930093
[TBL] [Abstract][Full Text] [Related]
11. Recombinant protein folding and misfolding in Escherichia coli.
Baneyx F; Mujacic M
Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
[TBL] [Abstract][Full Text] [Related]
12. Improving the productivity of recombinant protein in Escherichia coli under thermal stress by coexpressing GroELS chaperone system.
Kim SY; Ayyadurai N; Heo MA; Park S; Jeong YJ; Lee SG
J Microbiol Biotechnol; 2009 Jan; 19(1):72-7. PubMed ID: 19190411
[TBL] [Abstract][Full Text] [Related]
13. Engineering toward a bacterial "endoplasmic reticulum" for the rapid expression of immunoglobulin proteins.
Groff D; Armstrong S; Rivers PJ; Zhang J; Yang J; Green E; Rozzelle J; Liang S; Kittle JD; Steiner AR; Baliga R; Thanos CD; Hallam TJ; Sato AK; Yam AY
MAbs; 2014; 6(3):671-8. PubMed ID: 24517929
[TBL] [Abstract][Full Text] [Related]
14. Advances in Escherichia coli production of therapeutic proteins.
Swartz JR
Curr Opin Biotechnol; 2001 Apr; 12(2):195-201. PubMed ID: 11287237
[TBL] [Abstract][Full Text] [Related]
15. Revisiting Escherichia coli as microbial factory for enhanced production of human serum albumin.
Sharma A; Chaudhuri TK
Microb Cell Fact; 2017 Oct; 16(1):173. PubMed ID: 28982367
[TBL] [Abstract][Full Text] [Related]
16. Production of antibodies in SHuffle Escherichia coli strains.
Eaglesham JB; Garcia A; Berkmen M
Methods Enzymol; 2021; 659():105-144. PubMed ID: 34752282
[TBL] [Abstract][Full Text] [Related]
17. Roles and applications of small heat shock proteins in the production of recombinant proteins in Escherichia coli.
Han MJ; Park SJ; Park TJ; Lee SY
Biotechnol Bioeng; 2004 Nov; 88(4):426-36. PubMed ID: 15382106
[TBL] [Abstract][Full Text] [Related]
18. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
Hatfield GW; Roth DA
Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
[TBL] [Abstract][Full Text] [Related]
19. Current trends in biopharmaceuticals production in Escherichia coli.
McElwain L; Phair K; Kealey C; Brady D
Biotechnol Lett; 2022 Aug; 44(8):917-931. PubMed ID: 35796852
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli].
Chang GD; Li ZL; Qin JY; Ma CQ; Luo YZ; Xu P
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):662-6. PubMed ID: 16176112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
